Ambisome
Product Images NDC 0469-3051

5 FDA label images from Astellas Pharma Us, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ambisome (NDC 0469-3051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astellas Pharma Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Image 06)

Description (Image 06)
An illustration showing a cross section view of a liposome. The diagram labels the phospholipid bilayer forming the spherical liposome structure, with amphotericin B molecules embedded within the bilayer. This depiction is related to the drug AmBisome by Astellas Pharma US, Inc.*
FDA Label Image

Molecular Structure Of Amphotericin B (Image 02)

Molecular Structure Of Amphotericin B (Image 02)
Chemical structure of the active ingredient shown on the AmBisome product label, depicting a detailed molecular diagram with multiple hydroxyl groups and complex ring structures.*
FDA Label Image

Mean Change In Creatinine Over Time In Study 94-0-002 (Image 03)

Mean Change In Creatinine Over Time In Study 94-0-002 (Image 03)
Line graph titled 'Mean Change in Creatinine Over Time in Study 94-0-002' showing mean change in creatinine levels (mg/dL) over weeks on study for two treatments. The treatments compared are AmBisome 3 mg/kg/day and Amphotericin B 0.6 mg/kg/day, with AmBisome represented by a line with triangle markers and Amphotericin B by a line with square markers. The graph covers 0 to 4 weeks with creatinine changes rising more steeply for Amphotericin B compared to AmBisome.*
FDA Label Image

Mean Creatine Concentrations Over Time (Image 01)

Mean Creatine Concentrations Over Time (Image 01)
Cross section view of a liposome illustrating the phospholipid bilayer and embedded amphotericin B molecules. The diagram highlights the structural arrangement within the liposome.*
FDA Label Image

Ambisome Carton (Image 05)

Ambisome Carton (Image 05)
AmBisome (amphotericin B) liposome for injection 50 mg single-use vial packaging label from Astellas Pharma US, Inc. The label includes drug contents, storage instructions at up to 25°C, and a warning that AmBisome is not interchangeable on a mg per mg basis with other amphotericin B products. The label also features manufacturer information, a barcode, and Gilead and Astellas logos.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.